CBLL (CeriBell, Inc.) Earnings per share growth rate in current year
CeriBell, Inc. (CBLL) ensures stable demand for AI epilepsy diagnostics regardless of market cycles. High barriers to entry are created by patents and strict FDA oversight. Scaling cloud services within clinics optimizes expenses. This chart of annual EPS growth provided by GURU.Markets demonstrates a trend where -41.70 determines the current value of the metric.
Financial and market metric breakdowns for CeriBell, Inc. (CBLL)
- share price and consensus valuation forecast:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio CeriBell, Inc.|CBLL - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient ceribell.com|CBLL - Company Debts|Debt to Book Value Ratio CeriBell EEG|CBLL - Company Long-Term Debts|Company Current Liabilities CeriBell|Interim Coverage Ratio ceribell.com
- earnings and valuation multiples information:
CBLL - Net Profit|Future Profit CeriBell, Inc.|CBLL - P/E Multiple|Future Price to Earnings CeriBell EEG|CBLL - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CeriBell EEG|CBLL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months CeriBell|CBLL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months ceribell.com|CBLL - Earnings growth in current year|Expected net earnings per share growth next year CeriBell, Inc.
Basic company analysis:CeriBell Inc
This indicator measures the year-over-year growth rate of earnings per share, allowing for an assessment of business scaling efficiency through real income dynamics. The absence of proprietary server costs due to infrastructure outsourcing reduces capital expenditures for CeriBell, Inc. (CBLL), which is directly reflected in the annual earnings per share growth rate, confirming the operational flexibility of the model.
Direct competitors
BIIB (Biogen Inc) - Earnings per share growth in current year|NBIX (Neurocrine Biosciences Inc) - Earnings growth in current year|Earnings per share growth rate in current year Regencell Corp RGC|Earnings per share growth in current year Axsome Therapeutics (AXSM)|Earnings per share growth in current year ACAD (acadia-pharm.com)|Earnings per share growth in current year Xenon XENE|Viking Therapeutics Inc - Earnings per share growth in current year|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (Catalyst Corp)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Earnings per share growth in current year Biohaven|Earnings per share growth this year AMLX (Amylyx Pharmaceuticals Inc)|Earnings growth in current year TRVI|Net earnings per share growth this year Praxis Corp PRAX|Anavex Life Sciences - Net earnings per share growth this year|Expected net earnings per share growth this year prothena.com (PRTA)|Alector Therapeutics - Earnings growth in current year|Annexon Biosciences (ANNX) - Net earnings per share growth this year|OMER: Earnings growth in current year|NGNE (Neurogene Therapeutics) - Earnings per share growth in current year|Earnings per share growth in current year AC Immune|Earnings per share growth in current year VYGR|Earnings per share growth in current year Neumora Therapeutics, Inc. (NMRA)|Earnings per share growth in current year SCLX (Scilex Holding)|Earnings per share growth in current year Tevogen Bio Holdings, Inc. TVGN|ACOG: Earnings per share growth this year|Cognition Therapeutics, Inc. - Earnings growth in current year|Earnings per share growth rate in current year inhibikase.com|SAVA (Cassava Sciences) - Net earnings per share growth this year|Assertio (ASRT) - Earnings growth in current year|Earnings per share growth in current year Coya Therapeutics Inc|VTGN: Earnings per share increase in current year|Earnings per share growth in current year Ovid Therapeutics Inc. (OVID)|ABOS - Earnings per share growth rate in current year|Earnings growth in current year CRVO (CervoMed)|ATHE - Net earnings per share growth this year|Clene Nanomedicine - Earnings growth in current year|Earnings per share growth rate in current year PepGen Inc.|Jupiter Neurosciences (JUNS) - Earnings per share growth in current year|relmada.com - Earnings per share increase in current year|ANVS (Annovis Bio) - Earnings growth in current year|Grace Tx (GRCE) - Expected net earnings per share growth this year|Earnings growth in current year AIFF|Earnings per share growth in current year KLTO (anewmeds.com)|Earnings growth in current year NRSN (NeuroSense Therapeutics Ltd.)|revivapharma.com (RVPH) - Earnings per share growth rate in current year|MTVA - Earnings per share growth in current year|NRXS: Earnings per share growth in current year|heliusmedical.com (HSDT) - Earnings per share growth in current year|PASG (Passage Bio) - Earnings per share growth in current year|Net earnings per share growth this year NEUP|NERV: Earnings per share increase in current year|Earnings growth in current year ATHA|Expected net earnings per share growth this year Addex Therapeutics Ltd.|Earnings per share growth in current year Alzamend Neuro ALZN|CYCN: Earnings per share growth this year|Protagenic - Earnings growth in current year|Pasithea Therapeutics (KTTA) - Net earnings per share growth this year|CRGT (cortigent.com) - Net earnings per share growth this year|ATXI - Expected net earnings per share growth this year|BCLI (Brainstorm Cell Therapeutics, Inc.) - Earnings growth in current year|Net earnings per share growth this year Cara Therapeutics Inc (CARA)|Earnings growth in current year CHRO|Earnings per share growth in current year ELYM (eliemtx.com)|Earnings per share growth in current year Intra-Cellular Therapies, Inc. ITCI|Longboard Pharmaceuticals Inc - Earnings per share growth in current year|MRNS - Earnings per share growth in current year|NKGN: Earnings per share growth in current year|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|Earnings per share growth this year SAGE|SNPX (Synaptogenix) - Earnings growth in current year|Earnings per share growth rate in current year Trevena Inc. TRVN|Net earnings per share growth this year VIGL (Vigil Neuroscience)|Earnings growth in current year anewmeds.com (WENA)|Earnings per share growth in current year Cerevel Therapeutics CERE
